Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLD10 in Hypomagnesemic Type 2 Diabetes
NCT03567824Phase 2Not yet recruiting
- Sponsor
- Pharmalyte Solutions
- Start
- Mar 2026
- Primary completion
- Apr 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of magnesium in hypomagnesemia, type 2 diabetes mellitus (T2DM), sponsored by Pharmalyte Solutions. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
magnesium
03
Conditions
hypomagnesemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03567824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567824.